✦ LIBER ✦

The modified Evan's blue dye procedure in the tracheostomized patient

✍ Scribed by Arlen D. Meyers

Publisher: Springer
Year: 1995
Tongue: English
Weight: 103 KB
Volume: 10
Category: Article
ISSN: 0179-051X
DOI: 10.1007/bf00260974

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The modified Evan's blue dye procedure f

The modified Evan's blue dye procedure fails to detect aspiration in the tracheostomized patient: Five case reports

✍ Sheri Thompson-Henry; Barbara Braddock 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 268 KB

Comment on Thompson-Henry and Braddock:

Comment on Thompson-Henry and Braddock: The modified Evan's Blue Dye procedure fails to detect aspiration in the tracheostomized patient: Five case reports

✍ Steven B. Leder 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 161 KB

Reconsidering the value of the modified

Reconsidering the value of the modified Evan's Blue Dye test: A comment on Thompson-Henry and Braddock (1995)

✍ Donna C. Tippett; Arthur A. Siebens 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 174 KB

Pure ileal Crohn's disease without colon

Pure ileal Crohn's disease without colonic involvement after a long ileo-colonic anastomosis (Lester Martin Procedure) for Hirschsprung's disease: An argument favoring a specific sensitivity of the ileum in a subset of patients with Crohn's disease

✍ Xavier Dray; Harry Sokol; Kouroche Vahedi; Anne Lavergne-Slove; Philippe Marteau 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB 👁 2 views

High dose chlorambucil versus Binet's mo

High dose chlorambucil versus Binet's modified cyclophosphamide, doxorubicin, vincristine, and prednisone regimen in the treatment of patients with advanced B-cell chronic lymphocytic leukemia : Results of an international multicenter randomized trial

✍ Branimir Jaksic; Maura Brugiatelli; Ivo Krc; Hajna Losonczi; Jerzy Holowiecki; A 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 2 views

vanced and/or progressive disease was defined by high Total Tumor Mass (TTM) score (ú9), and/or short doubling time (DT) (õ12 months), and/or bone marrow for the International Society for Chemo-Immunotherapy, Vienna failure. The response to therapy was defined by reduction of the initial TTM score.